This book documents Kathleen McLaughlin's ten-year investigation researching and reporting on the $20-billion-a year business she found at the other end of her medication, revealing an industry that targets America's most economically vulnerable for immense profit.
What The Reviewers Say
Tony Miksanek,
Booklist
McLaughlin’s distressing assessment of the plasma economy spotlights the value of the substance for patients, individuals in financial need who provide it, and big-business blood-traders who profit handsomely from it..
Adam Gaffney,
The New Republic
Illuminating.
Kirkus
If there was any doubt that the country’s wealth gap has grown untenably wide, this book dispels it.
Publishers Weekly
Throughout, [McLaughlin] interweaves shocking revelations about lax regulations, tainted blood, and potential side effects for frequent donors with piercing meditations on how it feels to know that her medication “is built on the backs of quiet, hidden economic desperation.” The result is a captivating and anguished exposé..